Overactive Bladder Research Study
This is a 4 to 5 month study for women with Overactive Bladder. The study will compare how well combining two already marketed medications for Overactive Bladder compares with just one of the medications. The study will combine Desmopressin (DDVP) with Tolterodine (Detrol) and compare the combination with Tolterodine mixed with placebo.
Compensation is available for each completed study visit.
You may qualify if the following apply to you: